Chronic Dengue Virus Panencephalitis in a Patient with Progressive Dementia with Extrapyramidal Features

Virome-wide CSF antibody profiling unmasks the first reported case of chronic CNS dengue infection after seven years of unexplained dementia.

Johnson TP, Larman HB, Lee MH, et al.

Annals of Neurology · November 2019 · DOI: 10.1002/ana.25588

How to cite

AMA

Johnson TP, Larman HB, Lee MH, et al. Chronic dengue virus panencephalitis in a patient with progressive dementia with extrapyramidal features. Ann Neurol. 2019;86(5):695-703. doi:10.1002/ana.25588

APA

Johnson, T. P., Larman, H. B., Lee, M. H., & Nath, A. (2019). Chronic dengue virus panencephalitis in a patient with progressive dementia with extrapyramidal features. Annals of Neurology, 86(5), 695–703. https://doi.org/10.1002/ana.25588

BibTeX

@article{johnson2019denguepanencephalitis,
  title   = {Chronic dengue virus panencephalitis in a patient with progressive dementia with extrapyramidal features},
  author  = {Johnson, Tory P. and Larman, H. Benjamin and Lee, Myoung-Hwa and Nath, Avindra},
  journal = {Annals of Neurology},
  volume  = {86},
  number  = {5},
  pages   = {695--703},
  year    = {2019},
  doi     = {10.1002/ana.25588}
}

A 45-year-old man enrolled in the NIH Undiagnosed Diseases Program presented with seven years of progressive dementia, extrapyramidal signs, and chronic CNS inflammation that resisted every standard diagnostic workup. Comprehensive antibody profiling against the human virome surfaced a strikingly enriched dengue virus signal in cerebrospinal fluid relative to serum — and postmortem analysis confirmed persistent wild-type dengue virus replication in the brain, the first reported case of chronic dengue panencephalitis.

In this publication:

Dengue virus is the most common mosquito-borne virus on Earth, with an estimated 390 million infections every year. Most are asymptomatic; severe disease is acute and self-limiting; chronic infection had never been documented. This case challenges that picture. A 45-year-old man with a five-year history of severe progressive dementia, involuntary movements, postural instability, and chronic CNS inflammation was referred to the NIH Undiagnosed Diseases Program after every standard diagnostic workup came back inconclusive.

Researchers screened the patient’s serum and cerebrospinal fluid against the entire human virome using VirScan, a phage-display library encoding peptides from every virus known to infect humans. Antibodies against dengue virus were strikingly enriched in CSF relative to serum — a pattern that did not appear for closely related flaviviruses such as Japanese encephalitis virus despite elevated serum titers. The compartment-specific signal pointed the team back to the brain itself.

Postmortem analysis confirmed dengue virus in the brain by immunohistochemistry, in situ hybridization, quantitative PCR, and sequencing. Dengue was also recoverable by PCR and sequencing from a brain biopsy collected 33 months antemortem, demonstrating a chronic infection sustained for years despite a robust antiviral antibody response. The work reframes how clinicians should approach undiagnosed encephalitis in dengue-endemic regions and in patients with travel histories — and it shows how unbiased virome-wide antibody profiling can identify pathogens that targeted assays were never built to detect.

← Back to all resources

Related resources

Brochure

HuSIGHT and EnviroSIGHT — InSIGHTs for Parkinson's Disease

HuSIGHT + EnviroSIGHT for Parkinson's research: environmental triggers and autoimmune contributions in one assay.

Read more
White Paper

Unbiased analysis of antibody responses to all human viruses using Infinity Bio's VirSIGHT library

A peer-reviewed methodology white paper for VirSIGHT, Infinity Bio's unbiased antibody reactome assay covering 500+ huma…

Read more
Brochure

VirSIGHT InSIGHTs

VirSIGHT at a glance: antibody reactome profiling across the known human virome (500+ species).

Read more
Brochure

Antibody Reactomics: The Responsive Layer of Immune Memory

Where the antibody reactome fits in the multi-omic stack, how MIPSA deciphers it, and what the HuSIGHT, VirSIGHT, and En…

Read more
Publication

Viral Immunity in Immunoglobulin Products, Global Immunity Debt and Autoimmunity

Lindahl et al., 2026: viral immunity in IgG products and global immunity debt.

Read more
Publication

Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses

Antibody reactome profiling of bat reservoirs identifies emerging zoonotic potential for biosurveillance.

Read more
Publication

Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load

Frontiers Immunol 2023: pre-infection antibody reactome predicts post-infection HIV viral control.

Read more
Publication

Comprehensive profiling of antibody responses to the human anellome using programmable phage display

Antibody reactome profiling of the human anellome: small DNA viruses persisting in healthy hosts.

Read more
Publication

Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells

Females develop broader vaccine-induced antibody repertoires, driven by germinal-center B-cell diversity.

Read more
Publication

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik et al., Science 2022: 10M serial serum samples link EBV to multiple sclerosis.

Read more
Publication

Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait

Antibody epitope selection is partially heritable, shown across twin and SNP-genotyped cohorts.

Read more
Publication

Deconvoluting virome-wide antibody epitope reactivity profiles

Bioinformatic deconvolution of cross-reactive signals in virome-wide antibody reactome data.

Read more